TCL Archive Cohen Directs UK’s Markey Cancer Center; Matrisian Named Chairman, DOD Panel. September 8, 2000
TCL Archive NCI Needs 100 SBIR Contracts By April 1 To Avoid Losing $5 Million; NIH Objects To DCT Comments March 22, 1985
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005